Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Main Authors: | Katherine A. Michaelis, Mason A. Norgard, Xinxia Zhu, Peter R. Levasseur, Shamilene Sivagnanam, Shannon M. Liudahl, Kevin G. Burfeind, Brennan Olson, Katherine R. Pelz, Diana M. Angeles Ramos, H. Carlo Maurer, Kenneth P. Olive, Lisa M. Coussens, Terry K. Morgan, Daniel L. Marks |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-13151-z |
Similar Items
-
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
by: Katherine A. Michaelis, et al.
Published: (2019-10-01) -
MyD88 signalling is critical in the development of pancreatic cancer cachexia
by: Xinxia Zhu, et al.
Published: (2019-04-01) -
Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia
by: Brennan Olson, et al.
Published: (2021-04-01) -
R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes
by: Nian Hua, et al.
Published: (2012-01-01) -
39 Spatial single-cell quantitative analyses of human head and neck squamous cell carcinomas
by: Lisa Coussens, et al.
Published: (2020-11-01)